SEC Form 4 · accession 0000899243-17-017148
Mylan N.V. · MYL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph C Maroon M.D.
Director
Period of report
Jun 22, 2017
Accepted (ET)
Jun 23, 2017 · 7:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001623613
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Jun 22, 2017 | M | 3,653 | $0.00 | A | 29,256 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1 | $0.00 | Jun 22, 2017 | M | 3,653 | D | — | — | Ordinary Shares | 3,653 | 0 | D |
Explanation of responses
- F1Each restricted stock unit ("RSU") represents the right to receive one ordinary share of Mylan N.V. These RSUs vested in full on June 22, 2017 in connection with the conclusion of Dr. Maroon's service as a director on such date.